BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28521025)

  • 1. Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism.
    Yan M; Feng L; Shi Y; Wang J; Liu Y; Li F; Li B
    Toxicol Sci; 2017 Aug; 158(2):379-390. PubMed ID: 28521025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rescuable function and mechanism of resveratrol on As₂O₃-induced hERG K⁺ channel deficiency.
    Zhao X; Zhang KP; Huang T; Yan CC; Liu LR; Zhu QL; Guo FF; Liu C; Li BX
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Nov; 387(11):1079-89. PubMed ID: 25107562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome.
    Chu W; Li C; Qu X; Zhao D; Wang X; Yu X; Cai F; Liang H; Zhang Y; Zhao X; Li B; Qiao G; Dong D; Lu Y; Du Z; Yang B
    Cardiovasc Res; 2012 Oct; 96(1):90-8. PubMed ID: 22853924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Epicatechin rescues the As
    Dong Z; Shi Y; Feng L; Shen Z; Fang L; Zheng S; Hai X; Li B
    J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28768059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
    De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency.
    Yan M; Zhang K; Shi Y; Feng L; Lv L; Li B
    Drug Des Devel Ther; 2015; 9():5737-47. PubMed ID: 26543354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
    Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
    J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles.
    Yamazaki K; Terada H; Satoh H; Naito K; Takeshita A; Uehara A; Katoh H; Ohnishi K; Hayashi H
    Circ J; 2006 Nov; 70(11):1407-14. PubMed ID: 17062962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular Mechanism of Rosuvastatin-Induced Decrease in Mature hERG Protein Expression on Membrane.
    Feng PF; Zhang B; Zhao L; Fang Q; Liu Y; Wang JN; Xu XQ; Xue H; Li Y; Yan CC; Zhao X; Li BX
    Mol Pharm; 2019 Apr; 16(4):1477-1488. PubMed ID: 30807184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of miR-21 and miR-23a Contributes to As2 O3 -induced hERG Channel Deficiency.
    Zhao X; Shi YQ; Yan CC; Feng PF; Wang X; Zhang R; Zhang X; Li BX
    Basic Clin Pharmacol Toxicol; 2015 Jun; 116(6):516-23. PubMed ID: 25395240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.
    Fan Y; Chen M; Meng J; Yu L; Tu Y; Wan L; Fang K; Zhu W
    PLoS One; 2014; 9(8):e105890. PubMed ID: 25144547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Duncan G; Firth K; George V; Hoang MD; Staniforth A; Smith G; Denning C
    Stem Cells Dev; 2017 Dec; 26(23):1695-1705. PubMed ID: 28992755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein ameliorates adverse cardiac effects induced by arsenic trioxide through preventing cardiomyocytes apoptosis.
    Fan Y; Wang C; Zhang Y; Hang P; Liu Y; Pan Z; Wang N; Du Z
    Cell Physiol Biochem; 2013; 31(1):80-91. PubMed ID: 23363563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide-induced hERG K(+) channel deficiency can be rescued by matrine and oxymatrine through up-regulating transcription factor Sp1 expression.
    Zhang Y; Dong Z; Jin L; Zhang K; Zhao X; Fu J; Gong Y; Sun M; Yang B; Li B
    Biochem Pharmacol; 2013 Jan; 85(1):59-68. PubMed ID: 23103450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome.
    Wan X; Dennis AT; Obejero-Paz C; Overholt JL; Heredia-Moya J; Kirk KL; Ficker E
    J Biol Chem; 2011 Jan; 286(4):2843-52. PubMed ID: 21097842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thioridazine Induces Cardiotoxicity via Reactive Oxygen Species-Mediated hERG Channel Deficiency and L-Type Calcium Channel Activation.
    Liu Y; Xu X; Zhang Y; Li M; Guo J; Yan C; Wang F; Li Y; Ding Y; Li B; Fan P
    Oxid Med Cell Longev; 2020; 2020():3690123. PubMed ID: 32064022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological characterization of cardiomyocytes derived from human induced pluripotent stem cells.
    Honda M; Kiyokawa J; Tabo M; Inoue T
    J Pharmacol Sci; 2011; 117(3):149-59. PubMed ID: 22027094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Tat protein inhibits hERG K+ channels: a potential mechanism of HIV infection induced LQTs.
    Bai YL; Liu HB; Sun B; Zhang Y; Li Q; Hu CW; Zhu JX; Gong DM; Teng X; Zhang Q; Yang BF; Dong DL
    J Mol Cell Cardiol; 2011 Nov; 51(5):876-80. PubMed ID: 21820442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Successful treatment of relapsed and refractory acute promyelocytic leukemia with arsenic trioxide (As2O3)].
    Tanaka Y; Komatsu H; Ishii K; Nakamura F; Hayashi T; Sawada H; Ono Y; Imanaka T
    Rinsho Ketsueki; 2000 Apr; 41(4):354-7. PubMed ID: 10846468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.